Fresenius Medical Care AG (ETR:FME – Get Free Report) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of €37.77 ($39.76) and traded as high as €45.28 ($47.66). Fresenius Medical Care shares last traded at €45.10 ($47.47), with a volume of 235,939 shares trading hands.
Fresenius Medical Care Price Performance
The stock has a market cap of $13.38 billion, a price-to-earnings ratio of 24.92, a P/E/G ratio of 0.42 and a beta of 0.86. The company has a debt-to-equity ratio of 77.56, a current ratio of 1.46 and a quick ratio of 0.80. The stock’s 50 day simple moving average is €40.26 and its two-hundred day simple moving average is €37.77.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Read More
- Five stocks we like better than Fresenius Medical Care
- 3 REITs to Buy and Hold for the Long Term
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Most active stocks: Dollar volume vs share volume
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.